ET
BBIO icon

Entropy Technologies’s BridgeBio Pharma BBIO Stock Holding History

Entropy Technologies’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.02M Buy
+27,148
New +$1.9M 0.08% 325
2026
Q1 		– Sell
-11,255
Closed -$861K – 898
2025
Q4 		$861K Buy
11,255
+3,204
+40% +$210K 0.05% 420
2025
Q3 		$418K Sell
8,051
-30,642
-79% -$1.49M 0.03% 573
2025
Q2 		$1.67M Buy
+38,693
New +$1.41M 0.13% 220
2024
Q1 		– Sell
-29,123
Closed -$1.18M – 715
2023
Q4 		$1.18M Buy
+29,123
New +$875K 0.22% 166

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Entropy Technologies's BBIO Position: Q2 2026 in Review

Entropy Technologies opened a new position in BridgeBio Pharma (BBIO) in Q2 2026: 27,148 shares worth $2.02M. The stake represents 0.08% of the portfolio and ranks #325 among its holdings. This is a return to the name: Entropy Technologies previously reported a position in BBIO as recently as Q4 2025.

Entropy Technologies first reported a position in BBIO in Q4 2023 and has held it in 5 quarters since. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • Entropy Technologies held 27,148 shares of BridgeBio Pharma worth $2.02M as of Q2 2026.
  • BridgeBio Pharma was a new Entropy Technologies position in Q2 2026.
  • BridgeBio Pharma made up 0.08% of Entropy Technologies's portfolio in Q2 2026, its #325 holding.
  • Entropy Technologies first reported a position in BridgeBio Pharma in Q4 2023 and has held it in 5 quarters since.
  • 474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Entropy Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.